Close
Smartlab Europe
Achema middle east

Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and...

Lufthansa Cargo clears the new CSafe RAP Temperature-Controlled Container for departure

CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is pleased to announce that Lufthansa Cargo is the latest airline to qualify and approve the CSafe RAP for flight Lufthansa Cargo has approved...

Clinerion partners with the Dresden International University to generate Real World Evidence from a RWD Network for the first time in an academic setting

The Master’s Program in Clinical Research (MPCR) at Dresden International University (DIU) educates clinicians, scientists and related professionals from around the world in traditional and modern forms of clinical research in a collaborative, blended approach. With the advent of...

Aptar’s Nasal Unidose Device Approved by US FDA for First Needle-Free Rescue Treatment for Severe Hypoglycemia

AptarGroup, Inc. , a global leader in dispensing and drug delivery solutions, announced that its Unidose Powder System was recently approved by the U.S. FDA for an intranasal, needle-free rescue treatment drug intended to treat severe hypoglycemia in people...

Clariant Adds Pharmaceutical Desiccant Packet Production Capability in Cuddalore, India

The Clariant Healthcare Packaging business unit is now producing desiccant packets at its plant in Cuddalore, Tamil Nadu, India. The addition expands the range of desiccant products immediately available to customers in the region and increases global capacity. The plant...

MedPharm Expands Relationship With Novan On Formulation Science

MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with biopharmaceutical company Novan Inc. MedPharm has previously supported Novan by testing the company’s unique formulations using its proprietary in vitro models to optimise Novan’s formulations...

Boehringer Ingelheim Expands Idiopathic Pulmonary Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

Boehringer Ingelheim and Bridge Biotherapeutics Inc. announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeutics’s autotaxin inhibitor BBT-877 for patients with fibrosing interstitial lung diseases, including IPF. BBT-877 is...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »